AIML.CN AI ML Innovations (CNQ) C$0.035 Mar 31 2026: small-cap AI health view

We open market hours noting AIML.CN stock trades at C$0.035 on Mar 31 2026 on the CNQ exchange in Canada. This price sits near the year low of C$0.030 and well below the year high C$0.120, reflecting a low‑price, high‑volatility small cap in the healthcare AI/ML niche. We use Meyka AI, an AI-powered market analysis platform, to frame valuation, liquidity and a model forecast for investors.

AIML.CN stock current snapshot

AI/ML Innovations Inc. (AIML.CN) is trading at C$0.035 with volume 1,127,344 shares versus an average volume of 413,110, showing elevated activity today. The company is listed on the CNQ exchange in Canada and has 168,264,000.00 shares outstanding and a market cap of C$5,889,240.00.

The firm operates in digital healthcare using AI and machine learning and reports trailing EPS of -0.03 and a PE of -1.17, signalling ongoing losses while it builds product and market traction.

Financials and valuation metrics for AIML.CN stock

AIML.CN shows high valuation multiples relative to revenue: price to sales is 35.00, price to book is 4.58, and EV-to-sales is 29.43, underlining a valuation premium relative to tiny revenue per share. The company’s revenue per share TTM is 0.00079 and net income per share TTM is -0.03104, reflecting negative profitability.

Liquidity on the balance sheet is modest with cash per share 0.00532 and a current ratio of 2.09, but operating cash flow per share is negative at -0.02635, which increases financing risk if revenue growth does not accelerate.

Trading, volume and liquidity signals

Today’s volume of 1,127,344 equals a relative volume of 2.73, indicating above‑average trading interest and potential short-term volatility. The 50-day average price is 0.0373 and the 200-day average price is 0.04605, both above today’s price and signaling a downtrend over the medium term.

Average daily volume and the company’s small market cap make AIML.CN vulnerable to large intraday moves on low absolute liquidity, which raises execution risk for larger orders and increases short-term volatility.

Meyka AI rates AIML.CN with a score out of 100

Meyka AI rates AIML.CN with a score out of 100: the platform assigns a score 62.03 (Grade B) and suggests HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

Meyka AI’s forecast model projects a near-term monthly figure of C$0.020 and a yearly projection around C$0.0217. Compared with the current price C$0.035, the model implies roughly -37.9% downside to the yearly forecast. Forecasts are model-based projections and not guarantees.

Technical picture and sector context for AIML.CN stock

Technically the stock shows muted momentum with RSI 45.06, ADX 17.70 (no clear trend), and Bollinger band midpoint near C$0.04, which places the current price at the lower band and suggests limited upside in the very short term. The 50/200 averages point lower than current price, consistent with recent weakness.

Sectorwide, Healthcare in Canada is under pressure YTD with performance negative and peers showing mixed results, which adds headwinds for a small digital-health AI company with limited revenue history.

Risks and opportunity checklist

Key risks include low revenue per share, negative EPS, and a high price-to-sales ratio that demands material growth to justify the valuation. Operational metrics show long receivable days and a cash burn pattern that could require financing if growth stalls.

Opportunities hinge on product adoption of its personal health monitoring system, potential partnerships with care providers, and any patent progress. A bull case would require visible revenue growth, improved margins and stable cash flow to move multiples supportably higher.

Final Thoughts

AIML.CN stock trades at C$0.035 on Mar 31 2026 and remains a speculative, small‑cap play in AI-enabled digital healthcare. Valuation metrics such as P/S 35.00 and PB 4.58 demand meaningful revenue expansion to justify current pricing. Trading volume of 1,127,344 and relative volume 2.73 point to short‑term volatility that active traders can exploit, but it increases execution risk for larger investors. Meyka AI’s model projects a yearly level near C$0.022, implying about -37.9% from today’s price; that projection informs our cautious stance. We provide a scenario price target set: Bear C$0.020 (‑42.86%), Base C$0.040 (+14.29%), Bull C$0.100 (+185.71%), with outcomes tied to revenue traction, cash flow improvement and sector momentum. Forecasts are model-based projections and not guarantees. Use position sizing and stop management if trading AIML.CN, and monitor quarterly updates and partnerships as catalysts

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.